Interference of 6β-hydroxycortisol in the quantitation of urinary free cortisol by immunoassay and its elimination by solid phase extraction

Clinical Biochemistry

Volumn 31, Issue 4, 1998, Pages 229-233

  Lee, Chul ^a   Goeger, Douglas E ^b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

6 hydroxycortisol; Cross reactivity; Immunoassay; Interference; Solid phase extraction; Urinary free cortisol

Indexed keywords

6BETA HYDROXYHYDROCORTISONE; HYDROCORTISONE;

ARTICLE; CONTAMINATION; CROSS REACTION; DIAGNOSTIC ACCURACY; HYDROCORTISONE URINE LEVEL; IMMUNOASSAY; PRIORITY JOURNAL; SOLID PHASE EXTRACTION;

CHEMICAL FRACTIONATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS REACTIONS; HUMANS; HYDROCORTISONE; IMMUNOASSAY;

EID: 0032100837     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(98)00025-3     Document Type: Article

References (16)

1. 1. Robin P, Predine J, Milgrom E. Assay of unbound cortisol in plasma. J Clin Endocrinol Metab 1977; 46: 277-83.
2. 2. Ekins R. Measurements of free hormones in blood [review]. Endocrine Rev 1990; 11: 5-46.
3. 3. Hellman L, Nakada F, Curti J. Cortisol is secreted episodically by normal man. J Clin Endocrinol Metab 1970; 30: 411-22.
4. 4. Reynolds JW. Serum total corticoid and cortisol levels in premature infants with respiratory distress syndrome. Pediatrics 1973; 51: 884-90.
5. 5. Morineau G, Gosling J, Patricot MC. Convenient Chromatographic prepurification step before measurement of urinary cortisol by radioimmunoassay. Clin Chem 1997; 43: 786-93.
6. 6. Breckenridge AM. Clinical implications of enzyme induction. In: Parke DV, Ed. Enzyme induction. Pp. 274-301. London: Plenum Press, 1975.
7. 7. Ged C, Rouillon JM, Pichard L. The increase in urinary excretion of 6β-hydroxycortisol as a marker of human hepatic cytochrome P450 IIIA induction. Br J Clin Pharmacol 1989; 28: 373-87.
8. 8. Saenger P, Forster E, Kream J. 6β-hydroxycortisol: a noninvasive indicator of enzyme induction. J Clin Endocrinol Metab 1981; 52: 381-4.
9. 9. Ohnhaus EE, Park BK. Measurement of urinary 6β-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin. Eur J Clin Pharmacol 1979; 15: 139-45.
10. 10. Ohnhaus EE, Breckenridge AM, Park BK. Urinary excretion of 6β-hydroxycortisol and the time course measurement of enzyme induction in man. Eur J Clin Pharmacol 1989; 36: 39-46.
11. 11. Nieschlag E, Wickings EJ. A review of a radioimmunoassay for steroids. Z Klin Chem Klin Biochem 1975; 13: 261-71.
12. 12. Kroll MH, Ruddel M, Blank DW, Elin RJ. A model for assessing interference. Clin Chem 1987; 33: 1121-3.
13. 13. Lykkesfeldt J, Loft S, Poulsen HE. Simultaneous determination of urinary free cortisol and 6β-hydroxycortisol by high-performance liquid chromatography to measure human CYP3A activity. J Chromatogr B 1994; 660: 23-9.
14. 14. Lee C. Urinary 6β-hydroxycortisol in humans: analysis, biological variations, and reference ranges. Clin Biochem 1995; 28: 49-54.
15. 15. Sugimura T. Carcinogenicity of mutagenic heterocyclic amines formed during the cooking process. Mutat Res 1985; 150: 33-41.
16. 16. Guengerich FP. Characterization of human microsomal cytochrome P-450 enzymes. Annu Rev Pharmacol Toxicol 1989; 29: 241-64.